Burloza, Mark Yhurrie .
HRN: 21-74-13 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
CEFUROXIME 750MG (VIAL)
08/03/2022
08/09/2022
IV
750mg IV
Q8hrs
Uti
Waiting Final Action